login
  Password reminder
Vascular News
Contact the editor Visit Vascular News Twitter feed Visit Vascular News Facebook page
 

Patrick Peeters


Thursday, 19 Jan 2012 13:27

Patrick Peeters, chief, Department of Cardiovascular Surgery, Imelda Hospital, Bonheiden, Belgium, followed his father’s and grandfather’s footsteps into surgery. Specialising in cardiac, thoracic and vascular surgery, some of his greatest moments took place when he implanted endovascular devices for the first time. With rapid evolution in the endovascular world, “our cathlab has become a ‘museum’ of endovascular devices,” he says.



When did you decide you wanted a career in medicine?


Even when I was a little boy, I did not want to be part of the herd. I became a scout in my childhood, and that helped me to develop leadership skills and creativity. I was fascinated by the way you can construct things with toys such as model buildings and Meccano. It is interesting to see how bolts and iron rods can be turned into useful objects. You just need to add the right pieces together and aim for perfection.


In 1971, I started my studies as a Doctor of Medicine at the Catholic University of Louvain, as the third generation of surgeons in my family (my father and grandfather both were general surgeons). I graduated in 1978 with major distinction. My interest in medicine is probably in the genes. Yet, medicine was not enough for me. At the same time I was studying criminology. Criminology gave me the chance to develop a critical view on society.


Why vascular and thoracic surgery?


In medicine, I specifically enjoyed the course on vascular and heart surgery. This was very new and spectacular and caught my attention immediately. As I was consumed by this novel interest, one of the lines in my future career was drawn.


After graduating, I received further training at the Louvain University Hospital between 1978 and 1983. During this period I was trained as a general surgeon under the supervision of Jaques Gruwez, and as a cardiovascular and thoracic specialist under the supervision of G Stalpaert, R Suy, and G Deneffe.


Originally, I was to follow in the footsteps of my father, who had his own hospital, but because of my interest for vascular and heart surgery, this never happened.


I joined the Royal Belgian Society for Surgery in 1980 and the Flemish Surgeons’ Syndicate in 1982. In 1984, I was officially recognised as a general surgeon with cardiac, thoracic and vascular specialties. In August of the same year, I was appointed vascular and thoracic surgeon at the Imelda Hospital in Bonheiden, Belgium, where I am still active today.


How have endovascular therapies changed your career?


The introduction of endovascular therapy came as a tremendous gift to me. Even though I was trained as a classical vascular surgeon, these minimally invasive techniques were right up my alley. This new field of experience granted me a way to bundle my interests and creativity. I was lucky to be able to turn my hobbies (Meccano) into my work.


In 1987, I initiated my first peripheral endovascular programme, focusing on laser ablation of the superficial femoral artery. One year later, I became a member of the International College of Surgeons (Belgian Section) and the International Union of Angiology.


I became a member of the European Society for Vascular Surgery in July 1988, and have been a loyal adherent to the society ever since. In 1989, I became a member of the Union of Belgian Specialists (and its subdivision Professional Union of Belgian Surgeons).


In the beginning of the 90s, I developed an endovascular unit within the Imelda Hospital. Here, I performed and trained specialists in the newest endovascular techniques, comprising EVAR cases as well as peripheral percutaneous transluminal angioplasty and stenting. Within this setting, I organised workshops and trainings on a regular basis, next to my proctoring activities. Also, each year two international fellows receive endovascular training at the Imelda Hospital.


In 1991, I founded the Flemish Endovascular Surgeons, which offered a more structured and elaborate platform for the organisation of symposia and for the motivation and training of peripheral vascular surgeons in endovascular techniques. This is the reason why today vascular surgeons in Belgium perform endovascular procedures themselves.


In 1992, I was one of the founding members of the Belgian Society for Vascular Surgery.


You have founded a clinical research organisation with Marc Bosiers. How does it work?


We founded the Flanders Medical Research Program (FMRP) in 1995. This project grew out of the knowledge that one plus one is more than two. Instead of working separately on your own island, working together expands possibilities and results. This organisation gave us the possibility to do medical research, data management, copywriting and workshop organisation. If someone had told me during my student years I would be committing myself to rigorously collecting and writing down patient data in order to make further analysis of them, I would have laughed. Yet the FMRP platform granted us the possibility of doing this.


Participation in important clinical trials, which are likely to change patient care, is for me a source of gratification. Also having the opportunity to contribute to the education of young surgeons via workshops and training is very satisfactory.


Patrick Peeters
Patrick Peeters

Who has inspired you in your career?

 

Prof Suy inspired me in my career. He taught me a very good lesson of humility: “Pride comes before a fall.” Also Dr Ted Diethrich and Dr Julio Palmaz, who achieved some milestones in the endovascular field, are inspiring to me.

 

The recurring theme throughout all of this was the constant support of my father, who always taught me that kindness to the patient and competence are the cornerstones of medical practice.



Which technique/technology has had a profound effect on your career?

 

I remember the occasion when I learnt in a conference that Ted Diethrich and Giancarlo Biamino had used laser to treat a femoral stenosis. Of course, this made me curious. In our hospital there was a Yag Sharplan Laser available to gastroenterologists to do recanalisation of tumours in the rectum and colon. As these procedures were done under general anaesthesia, this laser was in the operating theatre. I then wondered: “Could we use this to treat artery stenosis?” This was the first tentative step towards an endovascular approach. The next step was the use of a guidewire and a balloon.

 

Congresses such as iCON, CX and VEITHsymposium still fascinate me. At such congresses, I can introduce new devices and techniques and discuss vascular disease with colleagues and their approach to treat them.

 

How has vascular surgery evolved since you began your career?

 

Amazing and fascinating things have happened over the past 20 years. Endovascular techniques have become less invasive and efficient; for example, the treatment of abdominal aortic aneurysms with an endoprosthesis. This was a great evolution, and is so much better for the patient. More new and promising devices are on the market. I participated in a lot of trials with new endovascular devices. Our cathlab has become a “museum” of endovascular devices.

 

What have your proudest moments been?

 

My proudest professional moments are: The first implant of a nitinol self-expandable stent (1991), the first implant of an endoprosthesis (1995, together with Claude Mialhe), the first endovascular intervention in a carotid lesion with a 0.035” device and the first implant of a bioabsorbable stent. Seeing a patient who could not walk being able to walk again makes me happy and proud every time. Patient care is always rewarding.

 

How do you see the vascular surgical field developing in the future?

 

There will be more and more need for prevention of atherosclerosis. More efficient devices and techniques will become available. Gene therapy will probably expand.

 

What are your interests outside medicine?

 

My interests outside medicine are playing golf, sailing and travelling. I also like Burgundy wine.

 

Fact File

 

Training and activities

 

1978  Doctor of Medicine, major distinction, Catholic University of Louvain

1982  Licentiate in Criminology, Catholic University of Louvain

1984  Recognised as general surgeon with cardiac, thoracic and vascular speciality

1984  Employed as vascular and thoracic surgeon in the Imelda Hospital in Bonheiden, Belgium

1985  Chief of the department of Cardiovascular Surgery

 

Surgical Training

 

  • Training of General Surgery, Catholic University of Louvain (Supervision Prof J Gruwez)
  • Training of Cardio-Vascular and Thoracic Surgery, Catholic University of Louvain (Supervision Prof G Stalpaert, Prof R Suy, Prof G Deneffe)

 

Memberships

 

  • Royal Belgian Society for Surgery (RBSS)
  • Belgian Society for Vascular Surgery (BSVS) – treasurer 1996–2000, secretary 2000–2002 and 2006–2010, president 2002–2006 and since 2010
  • Working group of Endovascular Surgery and Diagnosis Department of the Belgian Society for Vascular Surgery – president 1996–2008
  • International Society of Endovascular Specialists (ISES) – member of the Board for International Relations since 1996, treasurer 1998–2004, secretary since 2005
  • International College of Surgeons (Belgian section)
  • International Society for Cardio-Vascular Surgery (ISCVS)
  • European Society for Cardio-Vascular Surgery (ESCVS)
  • European Society for Vascular Surgery (ESVS)
  • International Union of Angiology

 

Journals

 

  • Member of the editorial board of Journal of Endovascular Therapy, Endovascular Today, Tijdschrift voor Geneeskunde, and Acta Chirurgica Belgica
  • Reviewer of Journal of Endovascular Therapy, Endovascular Today, and Acta Chirurgica Belgica

 

Numbers

 

  • 123 publications
  • 464 lectures
  • Involvement in 89 congresses


Add New Comment

Most popular


ROADSTER trial studying new path to carotid revascularisation completes patient enrolment
Friday, 18 Jul 2014
The trial was the first of its kind to study the treatment of carotid artery stenosis by placing a stent via direct access to the common carotid artery in the neck in an entirely new minimally ... ROADSTER trial studying new path to carotid revascularisation completes patient enrolment

Endovascular-first strategy for aortoiliac lesions irrespectively of TASC category
Thursday, 17 Jul 2014
Two-year data from a prospective, multicentre study suggest that endovascular therapy with stenting may be considered the preferred first-line treatment option for aortoiliac lesions, irrespectively ... Endovascular-first strategy for aortoiliac lesions irrespectively of TASC category

Similar results with elective post-EVAR open conversion and primary open juxtarenal aneurysm repair for type Ia endoleak
Wednesday, 13 Aug 2014
Elective open surgical conversion for type Ia endoleak after endovascular aneurysm repair (EVAR) is not associated with increased morbidity or mortality compared with open juxtarenal aneurysm repair ... Similar results with elective post-EVAR open conversion and primary open juxtarenal aneurysm repair for type Ia endoleak

Features


SPECT can predict cardiovascular mortality in elective aneurysm repair patients
Wednesday, 12 Mar 2014
Kimihiro Komori and Yosuke Inoue analyse the results of a study that concluded that preoperative pharmacologic stress myocardial perfusion SPECT is not only safe, but is also a useful method to ... SPECT can predict cardiovascular mortality in elective aneurysm repair patients

Hybrid techniques for the arch: are they effective and durable?
Monday, 17 Feb 2014
Piergiorgio Cao writes that despite the perioperative mortality risk, the late outcome of endovascular arch repair presents a low rate of aorta-related deaths and reinterventions and acceptable mid-... Hybrid techniques for the arch: are they effective and durable?

Profiles


Cliff Shearman
Thursday, 03 Jul 2014
A former president of the Vascular Society of Great Britain and Ireland, Cliff Shearman was ... Cliff Shearman

Andrew Holden
Tuesday, 11 Feb 2014
Andrew Holden has been involved in the investigation of several endovascular devices for the ... Andrew Holden

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions